Do I need an in-person exam for Ozempic in Illinois?

If you’re exploring weight loss medication like Wegovy, Ozempic, or Mounjaro, you’ve probably wondered: Can I get these medications through telehealth? The short answer is yes—in most cases, you can legally receive GLP-1 weight loss medications through a telehealth consultation without ever setting foot in a doctor’s office.

But the longer answer depends on where you live, who’s prescribing your medication, and how telehealth providers navigate an evolving patchwork of state and federal regulations. This guide breaks down everything you need to know about telehealth access to weight loss medications in 2025, including state-specific rules, provider qualifications, what to expect from your virtual visit, and how to avoid common pitfalls.

Federal Law: The Foundation for Telehealth Prescribing

At the federal level, telehealth prescribing for weight loss medications like Wegovy (semaglutide) and Mounjaro (tirzepatide) is fully legal. Here’s why:

GLP-1 Medications Are Not Controlled Substances

Unlike stimulant-based weight loss pills or ADHD medications (which are Schedule II controlled substances), GLP-1 receptor agonists like semaglutide and tirzepatide are non-controlled medications. This is a critical distinction. Under the Ryan Haight Act—a federal law designed to prevent online prescription drug abuse—controlled substances generally require an in-person medical exam before a prescription can be issued via telehealth.

Because GLP-1 medications fall outside this category, no federal law requires an in-person visit to prescribe them via telemedicine. A licensed healthcare provider can evaluate you through a live video consultation, review your medical history, and send your prescription electronically to a pharmacy—all without meeting you face-to-face.

COVID-Era Flexibilities Remain in Place (For Now)

During the COVID-19 pandemic, the Drug Enforcement Administration (DEA) temporarily waived the in-person exam requirement for all medications, including controlled substances. As of December 2025, these telehealth flexibilities have been extended through December 31, 2025, giving Congress and regulators more time to finalize permanent rules.

While this mainly affects controlled medications like Adderall or buprenorphine, the broader telehealth expansion has made virtual care the norm across all areas of medicine—including obesity treatment. Even if the DEA’s temporary flexibility expires, non-controlled weight loss medications will remain accessible via telehealth under existing federal law.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

State-by-State Differences: Where Telehealth Gets Complicated

While federal law sets the baseline, states have the final say on how telehealth is practiced within their borders. Some states welcome telehealth with open arms; others impose additional requirements that can complicate access to weight loss medications.

Three Key State Rules to Watch

1. In-Person Exam Requirements: A handful of states require an initial in-person physical exam before (or shortly after) starting telehealth treatment for weight loss medications.

2. Follow-Up Frequency: Some states mandate regular check-ins (e.g., every 30 days or every 3 months) to monitor patients on obesity medications.

3. Provider Scope of Practice: Whether Nurse Practitioners (NPs) and Physician Assistants (PAs) can prescribe independently—or need physician oversight—varies widely by state.

Let’s break down what this looks like in practice across the U.S.

State-by-State Telehealth Access for Weight Loss Medications

Below is a comprehensive look at telehealth prescribing rules in 17 key states (as of December 2025). Whether you’re in Texas, California, or anywhere in between, here’s what you need to know:

States with No In-Person Requirement (Telehealth-Friendly)

These states allow you to get weight loss medication entirely through virtual consultations:

California
Telehealth is fully permitted, and no in-person exam is required. Nurse Practitioners can practice independently (without physician supervision) after gaining 3+ years of experience. California’s forward-thinking telehealth laws make it one of the easiest states for virtual weight loss treatment.

Connecticut
No in-person visit required. However, providers must include behavioral counseling and a diet/exercise plan as part of obesity treatment. NPs gain independence after three years of collaboration with a physician.

Illinois
Telehealth prescribing is allowed without restrictions. All prescriptions must be sent electronically (a state requirement since 2023). NPs can prescribe with a written physician agreement.

New York
A telehealth-friendly state with full NP independence after 3,600 hours of experience. No special barriers to virtual weight loss care. Mandatory e-prescribing applies to all medications, including GLP-1s.

Pennsylvania
Telehealth is permitted, and no in-person exam is mandated for GLP-1 medications. NPs still require physician collaboration (independent practice regulations have not yet been finalized).

Washington
One of the most progressive telehealth states. No in-person requirement, and NPs have full prescriptive authority. Note: Washington’s My Health My Data Act (2023) imposes strict privacy rules on telehealth providers handling sensitive health information like weight loss data.

States Requiring an Initial In-Person Exam

These states generally support telehealth—but you’ll need at least one in-person visit before or shortly after starting treatment:

Arkansas
Known for some of the strictest telehealth rules in the country. An initial in-person exam is required to establish a valid patient-provider relationship. NPs must work under a physician collaboration agreement.

Delaware
Requires an initial physical exam before prescribing weight loss medications via telehealth. After that, follow-up visits can be virtual. NPs gain independence after two years of collaboration.

Georgia
An in-person exam is required before telehealth prescribing can begin. In 2024, Georgia passed a law allowing NPs and PAs to prescribe Schedule II controlled substances with physician delegation—a significant expansion of provider authority (though it doesn’t directly affect non-controlled GLP-1s).

Mississippi
State law requires at least one in-person evaluation for weight management therapy. NPs must practice under physician collaboration. Bills to expand NP independence are under consideration for 2025-2026.

New Jersey
One of the most rigorous states: providers must conduct a comprehensive in-person exam including labs, psychological screening, and informed consent before prescribing any weight loss medication. A detailed diet and exercise plan is also required. NPs need a joint protocol with a physician (full practice authority bills have stalled).

North Dakota
A hands-on initial evaluation is expected per state medical board guidance. After the first visit, telehealth follow-ups are permitted. NPs have full practice authority in this state.

South Carolina
Requires an initial in-person visit and periodic evaluations. NPs/PAs can prescribe under physician supervision with a written protocol. Legislation to expand NP independence has not advanced.

Texas
Generally expects an initial in-person exam for weight loss treatment. Texas has some of the strictest provider oversight rules: NPs and PAs must have a physician delegation agreement and cannot prescribe certain controlled medications independently. While GLP-1s are non-controlled (and thus can be prescribed under delegation), Texas law requires careful documentation and adherence to standard-of-care protocols.

Utah
An initial in-person exam is encouraged. NPs gained full practice authority in 2023, making Utah more telehealth-friendly than in prior years.

Virginia
State Board of Medicine rules require an initial physical exam, lab work, and a personalized diet/exercise plan before prescribing weight loss drugs. A follow-up within 30 days of starting therapy is also mandated. NPs can practice autonomously after two years of collaboration (since 2019).

States with Ongoing Monitoring Requirements

Florida
Telehealth is allowed, but state law imposes specific conditions: patients must have a BMI ≥30, and providers must schedule follow-up visits at least every 3 months during treatment. NPs may practice autonomously only in primary care settings (not obesity specialty clinics). This makes Florida somewhat restrictive for telehealth weight loss programs.

Who Can Prescribe Weight Loss Medications via Telehealth?

Not all telehealth providers are created equal. Depending on your state, you might see a physician (MD/DO), a Nurse Practitioner (NP), or a Physician Assistant (PA) for your virtual consultation. Here’s what you need to know:

Physicians (MDs and DOs)

All 50 states allow licensed physicians to prescribe GLP-1 medications via telehealth (as long as they’re licensed in the state where the patient is located). Physicians have full prescriptive authority and can order labs, adjust doses, and manage side effects without additional oversight.

Nurse Practitioners (NPs)

About 34 states plus Washington, D.C. now grant NPs full practice authority, meaning they can diagnose, treat, and prescribe medications independently without physician supervision. States like California, Washington, New York, and Arizona have embraced this model.

In states with collaborative or restricted practice (e.g., Texas, Florida, Pennsylvania), NPs must work under a physician collaboration or supervisory agreement. This doesn’t mean NPs are less qualified—it’s simply a legal requirement. Many telehealth platforms (including Klarity Health) employ NPs who are highly experienced in obesity medicine and work within their state’s scope-of-practice rules.

Physician Assistants (PAs)

PAs can prescribe weight loss medications in all states, but they generally require a supervising physician or collaborative agreement. The level of autonomy varies: some states allow PAs significant independence in day-to-day prescribing, while others require closer physician oversight.

Bottom line: Whether you see an MD, NP, or PA, you can trust that licensed telehealth providers are qualified to manage your weight loss treatment—as long as they’re operating within your state’s regulations.

What to Expect from a Telehealth Weight Loss Consultation

Reputable telehealth providers follow a structured process to ensure safety and effectiveness. Here’s what a typical journey looks like:

1. Initial Medical Screening

You’ll complete a detailed health questionnaire covering:

• Current weight, height, and BMI
• Medical history (diabetes, thyroid conditions, cardiovascular disease, etc.)
• Current medications and allergies
• Mental health history (depression, eating disorders)
• Family history of medullary thyroid cancer or multiple endocrine neoplasia (contraindications for GLP-1s)
• Previous weight loss attempts

2. Live Video Consultation

A licensed provider will review your medical history, discuss your weight loss goals, and assess whether you’re a good candidate for GLP-1 medications. They’ll explain:

• How the medication works
• Expected timeline for results (typically gradual weight loss over several months)
• Common side effects (nausea, GI upset, fatigue)
• The importance of combining medication with lifestyle changes (diet, exercise, behavioral therapy)

3. Lab Work and Baseline Assessment

Depending on your state and medical history, your provider may order baseline lab work:

• Comprehensive metabolic panel (kidney and liver function)
• Thyroid function tests (TSH)
• Hemoglobin A1C (if you have diabetes or prediabetes)

Some states (like New Jersey and Virginia) require this as part of the initial evaluation.

4. Prescription and Pharmacy Fulfillment

If you qualify, your provider will send an electronic prescription to your pharmacy of choice. Important: Reputable telehealth services only prescribe FDA-approved, brand-name medications (Wegovy, Ozempic, Mounjaro) or their authorized generics—not compounded versions.

As of May 2025, the FDA has banned most compounded semaglutide products due to safety concerns. Avoid any telehealth service offering ‘custom-compounded’ GLP-1s at suspiciously low prices—these are often unregulated and potentially unsafe.

5. Ongoing Monitoring and Follow-Up

Weight loss medication requires regular check-ins to monitor progress, adjust dosing, and manage side effects. Expect follow-up appointments:

• 1 month after starting (to assess tolerance and titrate dose)
• Every 2-3 months thereafter (or monthly, depending on state requirements)

Some states mandate more frequent visits—Florida requires at least one follow-up every 3 months, and Virginia requires a check-in within 30 days of starting treatment.

How Klarity Health Makes Telehealth Weight Loss Care Simple

At Klarity Health, we’ve designed our telehealth weight loss program to be accessible, affordable, and compliant with state-specific regulations. Here’s what sets us apart:

Licensed Providers in Your State

All Klarity providers are licensed and credentialed in the state where you reside. Whether you’re in Texas, California, or New Jersey, you’ll see a provider who understands your state’s specific rules and requirements.

Comprehensive Medical Evaluation

We don’t cut corners. Your initial consultation includes a thorough medical history review, BMI assessment, and discussion of your weight loss goals. If lab work is needed (or required by your state), we’ll guide you through the process.

Transparent Pricing

Klarity accepts both insurance and cash pay. If your insurance covers weight loss medications (coverage varies by plan), we’ll work with your insurer to maximize your benefits. If you’re paying out of pocket, you’ll know the cost upfront—no surprise bills.

Provider Availability

We know that traditional healthcare can mean waiting weeks for an appointment. Klarity offers same-day or next-day consultations in most states, so you can start your weight loss journey without unnecessary delays.

Ongoing Support

Weight loss is a journey, not a one-time prescription. Klarity providers schedule regular follow-ups to track your progress, adjust your treatment plan, and provide lifestyle coaching to help you reach your goals.

Red Flags: How to Spot Unsafe Telehealth Providers

The surge in demand for GLP-1 medications has attracted some questionable operators. Here’s how to protect yourself:

🚩 Red Flag #1: Guaranteed Prescriptions

Legitimate providers conduct a thorough medical evaluation before prescribing. If a website promises you’ll ‘definitely get a prescription’ or doesn’t require a live consultation, walk away.

🚩 Red Flag #2: Compounded or Overseas Medications

As of 2025, the FDA has banned most compounded semaglutide products. Any telehealth service offering ‘custom-compounded Wegovy’ or importing medications from overseas is operating in a legal gray area—or outright violating FDA regulations.

🚩 Red Flag #3: No Follow-Up Care

Weight loss medications require ongoing monitoring. If a service sends you a prescription and then disappears, that’s a major red flag. Reputable providers schedule regular check-ins to ensure your safety.

🚩 Red Flag #4: Lack of Transparency

Can’t find information about where the provider is licensed? No physical address or clinic affiliation? Vague pricing or hidden fees? These are warning signs of a potentially untrustworthy service.

Stick with established telehealth platforms like Klarity Health that prioritize patient safety, regulatory compliance, and transparent communication.

Common Misconceptions About Telehealth Weight Loss Medications

Misconception #1: ‘Anyone Can Get Ozempic Online for Quick Weight Loss’

Reality: Reputable telehealth providers screen carefully. You generally need a BMI of 30 or higher (or 27+ with obesity-related health conditions like diabetes or hypertension) to qualify for GLP-1 medications. If you’re only slightly overweight or seeking cosmetic weight loss, legitimate providers will recommend lifestyle changes instead.

Misconception #2: ‘These Are Just ‘Diet Pills’ I Can Take Casually’

Reality: GLP-1 medications are powerful tools for chronic weight management, not quick fixes. They work by regulating appetite and blood sugar—but they require commitment to lifestyle changes (diet, exercise, behavioral therapy) and regular medical monitoring.

Misconception #3: ‘Telehealth Providers Don’t Do Real Medical Evaluations’

Reality: Legitimate telehealth consultations are equivalent to in-person visits in terms of medical rigor. Providers review your full medical history, assess contraindications, order lab work when needed, and document everything in your medical record—just like a traditional doctor’s visit.

What’s Next for Telehealth Weight Loss Regulations?

The regulatory landscape for telehealth is evolving rapidly. Here’s what to watch in 2026 and beyond:

Federal Legislation (TREATS Act)

Congress is considering the TREATS Act (S.3048, reintroduced in October 2025), which would permanently allow telehealth prescribing of certain controlled substances—particularly for addiction treatment and mental health care. While this doesn’t directly affect GLP-1 medications, its passage would signal strong congressional support for expanding telehealth access across all areas of medicine.

DEA Telehealth Rules

The DEA’s temporary telehealth flexibility for controlled substances is set to expire on December 31, 2025. Most experts expect another extension or the finalization of permanent rules in early 2026. Even if the temporary rules lapse, non-controlled weight loss medications will remain fully accessible via telehealth under existing federal law.

State-Level Expansions

Several states are considering bills to expand NP/PA independence and streamline telehealth regulations:

• Mississippi has pending legislation to grant NPs full practice authority.
• Pennsylvania continues to work on finalizing NP independent practice regulations (enacted in 2016 but still awaiting implementation).
• States like Georgia and South Carolina may follow the lead of full-practice-authority states in 2026.

Bottom line: The trend is toward greater telehealth access with appropriate patient safeguards. Expect more states to align with flexible telehealth models in the coming years.

Frequently Asked Questions (FAQs)

Take the Next Step Toward Your Weight Loss Goals

If you’re ready to explore whether weight loss medication is right for you, telehealth offers a convenient, accessible, and clinically rigorous option. At Klarity Health, we’re committed to helping you achieve sustainable weight loss through evidence-based treatment, personalized care, and ongoing support.

Here’s how to get started:

1. Schedule a Consultation: Book a virtual appointment with a Klarity provider licensed in your state. We offer same-day and next-day availability in most areas.

2. Complete Your Medical Evaluation: Your provider will review your health history, discuss your goals, and determine if GLP-1 medications are appropriate for you.

3. Start Your Treatment Plan: If you qualify, we’ll send your prescription to your pharmacy and schedule regular follow-ups to monitor your progress.

4. Get Ongoing Support: Weight loss is a journey. We’ll be with you every step of the way—adjusting your treatment, providing lifestyle coaching, and celebrating your successes.

Ready to begin? Visit Klarity Health to schedule your consultation today. With transparent pricing, experienced providers, and acceptance of both insurance and cash pay, we make telehealth weight loss care simple and accessible.

Research Currency Statement

Verified as of: December 17, 2025
DEA Rules Status: DEA’s COVID-era telehealth flexibilities remain in effect through December 31, 2025. Non-controlled medications (like GLP-1 agonists) are not subject to the Ryan Haight Act’s in-person rule, so they can be prescribed via telehealth under federal law.
States Verified: AR, CA, CT, DE, FL, GA, IL, MS, NJ, NY, ND, PA, SC, TX, UT, VA, WA (as of December 2025)
Sources: 15 of 18 sources are from 2024-2025; older sources used only for baseline context.

⚠️ Note: Federal telehealth rules for controlled substances are temporary (set to expire 12/31/2025)—an additional extension or new rule is expected. State laws are constantly evolving; watch for changes in 2026 (e.g., pending NP practice authority bills, potential federal legislation like the TREATS Act). FDA oversight on compounded GLP-1 medications tightened in 2025—ensure compliance with current FDA guidance.

Sources and Citations

1. DEA Announcement – ‘DEA and HHS Extend Telemedicine Flexibilities through 2025’ (Nov 15, 2024). www.dea.gov

2. Axios News – ‘COVID-era telehealth prescribing extended’ (Nov 18, 2024). www.axios.com

3. McDermott Will & Emery Law – ‘DEA Extends Telemedicine Flexibilities for Controlled Substance Prescribing Through December 31, 2025’ (Nov 18, 2024). www.mwe.com

4. Goodwin Procter Law Alert – ‘Changing Regulatory and Reimbursement Landscape for Weight Loss Drugs’ (Mar 27, 2024). www.goodwinlaw.com

5. Reuters News – ‘Hims cut 4% of workforce amid ban on weight-loss drug copies’ (May 30, 2025). www.reuters.com

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,year%20extension
• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=telemedicine%20flexibilities%20through%20December%2031%2C,HHS%20on%20November%2015%2C%202024
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=,a%20final%20set%20of%20regulations
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=31%2C%202024.%20,In%20February%202023%2C%20the%20DEA
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=to%20perform%20an%20in,rule%20regarding%20telemedicine%20prescribing%20of
• https://www.whitehouse.senate.gov/news/release/whitehouse-murkowski-warner-blackburn-urge-white-house-and-dea-to-extend-telehealth-flexibilities-for-substance-use-disorder-and-mental-health-treatment/#:~:text=Whitehouse%2C%20Murkowski%2C%20Warner%2C%20Blackburn%20Urge,substance%20use%20disorder%20treatment%20Washington
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,person%20examination
• https://www.nextech.com/blog/semaglutide-laws-by-state#:~:text=Who%20can%20prescribe%20semaglutide%3F%20,
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,encounter%20to%20establish%20a%20valid